Gamma-Herpesvirus Latency Requires T Cell Evasion during Episome Maintenance
Open Access
- 22 March 2005
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Biology
- Vol. 3 (4) , e120
- https://doi.org/10.1371/journal.pbio.0030120
Abstract
The gamma-herpesviruses persist as latent episomes in a dynamic lymphocyte pool. Their consequent need to express a viral episome maintenance protein presents a potential immune target. The glycine–alanine repeat of the Epstein–Barr virus episome maintenance protein, EBNA-1, limits EBNA-1 epitope presentation to CD8+ T lymphocytes (CTLs). However, CTL recognition occurs in vitro, so the significance of such evasion for viral fitness is unclear. We used the murine gamma-herpesvirus-68 (MHV-68) to define the in vivo contribution of cis-acting CTL evasion to host colonisation. Although the ORF73 episome maintenance protein of MHV-68 lacks a glycine–alanine repeat, it was equivalent to EBNA-1 in conferring limited presentation on linked epitopes. This was associated with reduced protein synthesis and reduced protein degradation. We bypassed the cis-acting evasion of ORF73 by using an internal ribosome entry site to express in trans-a CTL target from the same mRNA. This led to a severe, MHC class I–restricted and CTL-dependent reduction in viral latency. Thus, despite MHV-68 encoding at least two trans-acting CTL evasion proteins, cis-acting evasion during episome maintenance was essential for normal host colonisation.Keywords
This publication has 56 references indexed in Scilit:
- Disruption of Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen Leads to Abortive Episome PersistenceJournal of Virology, 2004
- Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1The Journal of Experimental Medicine, 2004
- CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1The Journal of Experimental Medicine, 2004
- Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1Science, 2003
- The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Permits Replication of Terminal Repeat-Containing PlasmidsJournal of Virology, 2003
- Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.The Journal of Experimental Medicine, 1992
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984